Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.1202 | 84 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.22625 | 84 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.22031 | 84 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.28218 | 83 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.38522 | 85 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 6.22847 | 86 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.22475 | 85 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.2223 | 84 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.31272 | 85 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.2267 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.2212 | 84 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.3964 | 85 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.22359 | 84 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.1902 | 84 |